CD8A and neoplasm: Patients with CD8-high tumours had significantly better overall (HR 0.47, 95% CI 0.28–0.78, p = 0.003) and local progression free (HR 0.52, 95% CI 0.32–0.87, p = 0.011) survival (Figure 1).